ftInvstr
BIOFILCHEM · Healthcare ₹30.5 -1.39% Mkt Cap ₹49 Cr

BIOFILCHEM

Healthcare Drug Manufacturers - Specialty & Generic
₹30.5
-1.39% today · 30d +0.36%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for BIOFILCHEM. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹12 Cr
+91.99% YoY
NET PROFIT
₹0 Cr
-95.47% YoY
OPM
1.64%
-28.99pp YoY
EPS
₹0.07
PE 182.94
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-1.6% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
BIOFILCHEM182.94—
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
37
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 20
Valuation STRETCHED 5
Growth MUTED 49
Profitability AVERAGE 30
Technicals WEAK 47
Risk LOW 70
Key Stats
TTM PE
182.94
P/B
2.35
52W HIGH
₹46.34
OFF HIGH
-34.18%
DIV YIELD
0.0%
MKT CAP
₹49 Cr
◉ Active Signals
MACDNeutral0.2724
RSI(14)Neutral52.68
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold BIOFILCHEM and at what entry.

Sign up freeSign in